tiprankstipranks
Trending News
More News >
Denali Therapeutics (DE:4DN)
FRANKFURT:4DN
Germany Market

Denali Therapeutics (4DN) Income Statement

Compare
7 Followers

Denali Therapeutics Income Statement

Last quarter (Q4 2025), Denali Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Denali Therapeutics's net income was $-128.55M. See Denali Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 330.53M$ 108.46M$ 48.66M
Gross Profit
$ -11.18M$ 0.00$ 330.53M$ 108.46M$ 48.66M
Operating Expenses
$ 544.16M$ 487.34M$ 527.23M$ 449.21M$ 344.41M
Depreciation and Amortization
$ 14.81M$ 8.99M$ 16.73M$ 10.38M$ 8.59M
EBITDA
$ -497.63M$ -492.89M$ -179.97M$ -330.36M$ -287.16M
Operating Income
$ -555.34M$ -487.34M$ -196.70M$ -340.74M$ -295.75M
Other Income/Expenses
$ 42.90M$ 64.64M$ 51.51M$ 14.77M$ 4.59M
Pretax Income
$ -512.44M$ -422.70M$ -145.19M$ -325.97M$ -291.16M
Net Income
$ -512.54M$ -422.77M$ -145.22M$ -325.99M$ -290.58M
Per Share Metrics
Basic EPS
$ -2.97$ -2.57$ -1.06$ -2.60$ -2.39
Diluted EPS
$ -2.97$ -2.57$ -1.06$ -2.60$ -2.39
Weighted Average Shares Outstanding
175.46M 164.47M 137.37M 125.53M 121.52M
Weighted Average Shares Outstanding (Diluted)
175.46M 164.47M 137.37M 125.53M 121.52M
Currency in USD

Denali Therapeutics Earnings and Revenue History